NL-OMON56154撤回2 期
ORACLE: A long-term follow-up study to evaluate the safety and durability of GT005 in participants with geographic atrophy, secondary to age-related macular degeneration treated in a Gyroscope-sponsored antecedent study. - GT-ORACLE
试验速览
- 阶段
- 2 期
- 状态
- 撤回
- 入组人数
- 15
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •1. Able and willing to give written informed consent
- •2. Received GT005 in an antecedent study, GT005-02 (EXPLORE, NCT04437368 and
- •GT005-03 (HORIZON, NCT04566445)
- •3. Willing to attend study visits and complete the study procedures.
排除标准
- •Not Applicable. If the participant is not able to attend Week 96 visit (End of
- •Study visit for antecedent study) due to personal or medical reasons, the
- •Sponsor should be consulted, and participant asked to attend the Study Centre
- •at their next available opportunity to complete the Visit 1 for the ORACLE
研究者
相似试验
招募中
1 期
Study to evaluate the long term safety of GT005 in participants having macular degeneration that led to geographic atrophy in their eyes and that have been previously treated in a prior Gyroscope study using the same product.Geographic atrophy (GA) secondary to age-related macular degeneration (AMD) in participants already treated with GT005 in the GT005-02 (EXPLORE) and GT005-03 (HORIZON) antecedent studies.MedDRA version: 20.0Level: LLTClassification code 10075719Term: Atrophic age-related macular degenerationSystem Organ Class: 100000004853EUCTR2020-003987-22-NLGyroscope Therapeutics Ltd.200
进行中（未招募）
1 期
Study to evaluate the long term safety of GT005 in participants having macular degeneration that led to geographic atrophy in their eyes and that have been previously treated in a prior Gyroscope study using the same product.Geographic atrophy (GA) secondary to age-related macular degeneration (AMD) in participants already treated with GT005 in the GT005-02 (EXPLORE) and GT005-03 (HORIZON) antecedent studies.MedDRA version: 20.0Level: LLTClassification code 10075719Term: Atrophic age-related macular degenerationSystem Organ Class: 100000004853EUCTR2020-003987-22-ESGyroscope Therapeutics Ltd.200
进行中（未招募）
1 期
Study to evaluate the long term safety of GT005 in participants having macular degeneration that led to geographic atrophy in their eyes and that have been previously treated in a prior Gyroscope study using the same product.Geographic atrophy (GA) secondary to age-related macular degeneration (AMD) in participants already treated with GT005 in the GT005-02 (EXPLORE) and GT005-03 (HORIZON) antecedent studies.MedDRA version: 20.0Level: LLTClassification code 10075719Term: Atrophic age-related macular degenerationSystem Organ Class: 100000004853EUCTR2020-003987-22-IEGyroscope Therapeutics Ltd.300
进行中（未招募）
1 期
Study to evaluate the long-term safety of GT005 in participants having macular degeneration that led to geographic atrophy in their eyes and that have been previously treated in a prior Gyroscope study using the same product.Geographic atrophy (GA) secondary to age-related macular degeneration (AMD) in participants already treated with GT005 in the previous studies GT005-01 (FOCUS), GT005-02 (EXPLORE) and GT005-03 (HORIZON).MedDRA version: 20.0Level: LLTClassification code: 10075719Term: Atrophic age-related macular degeneration Class: 10015919CTIS2024-510946-15-00Gyroscope Therapeutics Limited163
进行中（未招募）
1 期
Study to evaluate the long term safety of GT005 in participants having macular degeneration that led to geographic atrophy in their eyes and that have been previously treated in a prior Gyroscope study using the same product.Geographic atrophy (GA) secondary to age-related macular degeneration (AMD) in participants already treated with GT005 in the GT-005-1 (FOCUS), GT-005-02 (EXPLORE) and GT005-03 (HORIZON) antecedent studies.MedDRA version: 20.0Level: LLTClassification code 10075719Term: Atrophic age-related macular degenerationSystem Organ Class: 10015919 - Eye disordersEUCTR2020-003987-22-DEGyroscope Therapeutics Ltd.225